Hsinchu, Taiwan

Shen Rong Lin

This inventor holds 1 USPTO granted patent. Top assignee: National Yang Ming Chiao Tung University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shen Rong Lin. Retrieved from https://idiyas.com/inventor/shen-rong-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shen Rong Lin in Protein Kinase Inhibition

Introduction

Shen Rong Lin is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of selective inhibitors for protein kinases. His work has the potential to impact various therapeutic areas, including cancer treatment.

Latest Patents

Shen Rong Lin holds a patent for "Selective inhibitors for protein kinases and pharmaceutical composition and use thereof." This invention provides a compound of formula (I) or the salt thereof, which is crucial for advancing the understanding and treatment of diseases related to protein kinases. He has 1 patent to his name, showcasing his innovative approach in this specialized field.

Career Highlights

Shen Rong Lin is affiliated with National Yang Ming Chiao Tung University, where he engages in research and development activities. His academic background and research focus have positioned him as a key figure in the study of protein kinases and their inhibitors.

Collaborations

He has collaborated with notable colleagues, including Kai-Cheng Hsu and Yun-Ming Wang, to further enhance the research and application of his inventions. Their combined expertise contributes to the advancement of knowledge in the field.

Conclusion

Shen Rong Lin's work in developing selective inhibitors for protein kinases represents a significant advancement in pharmaceutical innovation. His contributions are vital for future research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…